DNAV has released a new transmission router from Sierra Automated Systems (SAS), which the companies will demonstrate at the ...

Lungpacer Medical has announced that the U.S. Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) for the STARI (STimulation to Activate RespIration) clinical ...

Lungpacer Medical announced that it received FDA investigational device exemption (IDE) approval to begin a trial for its ...

The investigational AeroNova® System delivers continual diaphragm neurostimulation in conjunction with mechanical ventilation ...

The STARI trial (NCT06832306), a Phase 2 feasibility study, will explore the potential of transvenous diaphragm neurostimulation-assisted ventilation (DNAV) in mechanically ventilated patients ...